Recurrent Primary Peritoneal Serous Adenocarcinoma
2 clinical trials · Condition
◉ Watch Recurrent Primary Peritoneal Serous Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer (NCT02101788) | National Cancer Institute (NCI) | 2014-04-11 |
Track Recurrent Primary Peritoneal Serous Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.